Bristol-Myers Squibb Company BMY
63.19 USD +1.48 (+2.40%)
Nov 4, 2026, 12:16 PM EST
62.26 Day range 63.72
45.59 52-week range 68.09
- YTD
- +17.15%
- 1 year
- +38.60%
Analyst view
Consensus: buy
Buy
Price target (mean) 65.25 +3.3% upside
Now 63.19
- Target (low)
- 40.00
- Target (mean)
- 65.25
- Target (high)
- 80.00
Ratings (0m) 28 10 buy · 17 hold · 1 sell
- Strong buy4
- Buy6
- Hold17
- Sell1
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
- 3 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.50 | 1.32 – 1.63 | 1.26 | +19.3% | 12.66B | +1.3% | 21 |
| Next quarter | 1.51 | 1.31 – 1.68 | 1.58 | -4.2% | 11.13B | -3.1% | 9 |
| Current year | 6.43 | 6.18 – 6.57 | 6.15 | +4.6% | 50.16B | +4.1% | 24 |
| Next year | 6.65 | 5.72 – 7.56 | 6.43 | +3.4% | 48.66B | -3.0% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 5, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Sep 16, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Sep 10, 2026 | HSBC | Maintained | Hold | Hold |
| Aug 5, 2026 | Argus Research | Upgrade | Hold | Buy |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 31, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 31, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Jul 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Apr 9, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 8, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Apr 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Mar 17, 2026 | HSBC | Maintained | Hold | Hold |
| Feb 25, 2026 | RBC Capital | Initiated | — | Sector Perform |
| Feb 23, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 20, 2026 | Barclays | Initiated | — | Overweight |
| Feb 6, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 28, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 27, 2026 | Citigroup | Maintained | Neutral | Neutral |
